. 愛玩股

   玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退，要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益率 QoQ YoY稅後淨利率 QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
24Q3 (20)490.00.00.05-68.75150.00.06-40.0137.50.2426.32163.160.684.6236.035.47-12.8172.277.25-9.26144.183.92-67.09139.280.050.0162.50.03-62.5160.07.54-42.75179.873.92-67.09139.2835.65182.2992.50
24Q2 (19)490.00.00.16433.3300.10225.0200.00.19533.33167.860.6566.6714.0440.6817.4457.927.99190.18195.811.91208.553741.940.05266.67200.00.08700.0013.17274.151525.9311.91208.553741.9437.50272.44149.59
24Q1 (18)490.00.00.03111.54110.34-0.0874.1972.410.03104.69110.340.398.33-22.034.64418.56181.63-8.8677.4568.133.86110.82113.73-0.0378.5778.570.01107.69107.143.52110.09112.783.86110.82113.73-9.84-24.23-9.78
23Q4 (17)490.00.0-0.26-160.0-85.71-0.31-93.75-158.33-0.64-68.42-357.140.36-28.0-52.06.68-67.56-64.26-39.29-139.43-488.17-35.69-257.62-287.51-0.14-75.0-180.0-0.13-160.0-85.71-34.90-269.7-304.4-35.69-257.62-287.51-20.14-80.00-76.88
23Q3 (16)490.00.0-0.1000-0.16-60.0-60.0-0.38-35.7100.5-12.28-16.6720.59-20.07-10.52-16.41-96.76-106.16-9.98-3319.35-2395.0-0.08-60.0-60.0-0.0500-9.44-1265.43-2584.21-9.98-3319.35-2395.00.8650.002.76
23Q2 (15)490.00.00.00100.0-100.0-0.1065.52-600.0-0.283.45-2900.00.5714.0-12.3125.76109.43-15.98-8.3470.0-656.00.31101.1-95.95-0.0564.29-600.00100.0-100.00.81102.94-90.170.31101.1-95.95-9.66-3.57-38.07
23Q1 (14)490.00.0-0.29-107.14-222.22-0.29-141.67-190.0-0.29-107.14-222.220.5-33.33-12.2812.30-34.19-60.64-27.80-316.17-326.38-28.11-205.21-244.06-0.14-180.0-250.0-0.14-100.0-180.0-27.54-219.12-292.31-28.11-205.21-244.06-4.16-53.57-80.83
22Q4 (13)490.00.0-0.140-133.33-0.12-20.014.29-0.140-142.420.7525.015.3818.69-18.77-33.37-6.6816.0827.47-9.21-2202.5-107.9-0.050.016.67-0.070-133.33-8.63-2371.05-183.88-9.21-2202.5-107.98.65-50.00-310.00
22Q3 (12)490.00.00.00-100.00-0.10-600.0-350.00.00-100.0-100.00.6-7.69-10.4523.01-24.95-35.98-7.96-630.67-229.22-0.40-105.22-500.0-0.05-600.0-225.00-100.000.38-95.39-85.33-0.40-105.22-500.03.1755.56-240.00
22Q2 (11)490.00.00.10211.11-56.520.02120.0-94.590.01111.11-97.370.6514.04-50.030.66-1.89-6.551.50123.01-89.697.66193.76-12.360.01125.0-94.740.05200.0-54.558.24217.38-13.177.66193.76-12.360.8680.5674.28
22Q1 (10)490.00.0-0.09-50.0-156.25-0.1028.57-183.33-0.09-127.27-156.250.57-12.31-36.6731.2511.41-14.1-6.5229.21-186.59-8.17-84.42-195.67-0.0433.33-157.14-0.05-66.67-162.5-7.02-130.92-173.2-8.17-84.42-195.67-7.65-25.00-210.72
21Q4 (9)490.00.0-0.060-126.09-0.14-450.0-216.670.33-15.38-2.940.65-2.99-39.2528.05-21.95-16.02-9.21-249.51-250.0-4.43-4530.0-141.83-0.06-250.0-185.71-0.030-127.27-3.04-217.37-127.69-4.43-4530.0-141.83-25.73-50.00-269.60
21Q3 (8)490.00.00.00-100.0100.00.04-89.190.00.392.63254.550.67-48.46-23.8635.949.546.146.16-57.66103.970.10-98.86112.820.04-78.9533.330-100.0100.02.59-72.71517.740.10-98.86112.82-2.01-28.1259.57
21Q2 (7)490.00.00.2343.75360.00.37208.331950.00.38137.5216.671.344.4454.7632.81-9.81-3.2214.5593.2348400.08.742.34198.290.19171.4300.1137.5450.09.49-1.04217.398.742.34198.2914.276.66104.17
21Q1 (6)490.00.00.16-30.43128.570.120.0100.00.16-52.94128.570.9-15.892.2736.388.920.337.5322.64120.188.54-19.36112.970.070.0133.330.08-27.27100.09.59-12.66118.458.54-19.36112.972.851184.79100.00
20Q4 (5)490.00.00.232400.0-48.890.12200.0-33.330.34209.09-33.331.0721.59-4.4633.40-1.36-12.796.14103.31-30.3910.591457.69-46.270.07133.33-30.00.111200.0-50.010.981870.97-45.0710.591457.69-46.27--0.00
20Q3 (4)490.00.0-0.01-120.00.00.04300.00.00.11-8.330.00.884.760.033.86-0.120.03.029966.670.0-0.78-126.620.00.0300.0-0.01-150.00.0-0.62-120.740.0-0.78-126.620.0--0.00
20Q2 (3)490.00.00.05-28.570.0-0.02-133.330.00.1271.430.00.84-4.550.033.90-6.510.00.03-99.120.02.93-26.930.00-100.00.00.02-50.00.02.99-31.890.02.93-26.930.0--0.00
20Q1 (2)490.00.00.07-84.440.00.06-66.670.00.07-86.270.00.88-21.430.036.26-5.330.03.42-61.220.04.01-79.650.00.03-70.00.00.04-81.820.04.39-78.040.04.01-79.650.0--0.00
19Q4 (1)490.00.00.450.00.00.180.00.00.510.00.01.120.00.038.300.00.08.820.00.019.710.00.00.10.00.00.220.00.019.990.00.019.710.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/110.2910.68138.52.2724.140.75N/A本月營收較去年同期增加138.51%，主要係新增子公司業務所致。
2024/100.2628.0887.171.9816.110.71N/A本月營收較去年同期增加87.18%，主要係新增子公司業務所致。
2024/90.2-20.9754.761.729.870.680.72本月營收較去年同期增加54.76%，主要係新增子公司業務所致。
2024/80.2612.852.791.525.810.70.7本月營收較去年同期增加52.79%，主要係新增子公司業務所致。
2024/70.232.6211.631.27-0.350.70.7-
2024/60.22-13.7362.091.04-2.620.650.77本月營收較去年同期增加62.10%，主要係新增子公司業務所致。
2024/50.2643.7316.70.82-12.030.640.78-
2024/40.18-14.91-15.60.57-20.830.441.14-
2024/30.21310.35-4.730.39-23.010.391.42-
2024/20.05-60.46-62.830.18-37.050.281.96本月營收較去年同期減少 62.84%，主要係消化器類癌症用藥結束代理減少營收所致。
2024/10.1326.97-13.270.13-13.270.351.57-
2023/120.1-15.38-54.451.93-25.390.361.53本月營收較去年同期減少54.46%，主要係健檢事業營收減少所致。
2023/110.12-13.13-57.151.83-22.650.391.42本月營收較去年同期減少57.16%，主要係健檢事業營收減少所致。
2023/100.145.9-46.321.71-18.020.441.26-
2023/90.13-21.98-41.971.57-14.030.51.22-
2023/80.17-17.57-30.531.44-10.120.511.21-
2023/70.249.0150.811.27-6.510.561.09本月營收較去年同期增加50.82%，主要係健檢事業營收增加所致。
2023/60.14-37.89-21.351.07-12.790.571.22-
2023/50.223.94-6.260.93-11.380.651.06-
2023/40.21-3.96-15.20.72-12.840.571.22-
2023/30.2260.0912.210.5-11.820.51.61-
2023/20.14-7.7310.090.29-24.280.511.59-
2023/10.15-33.31-41.220.15-41.220.651.24-
2022/120.22-20.49.642.59-26.450.761.45-
2022/110.288.8229.342.36-28.660.761.45-
2022/100.2614.4811.522.08-32.720.721.52-
2022/90.22-6.5911.751.83-36.270.62.1-
2022/80.2478.93-10.011.6-39.890.552.3-
2022/70.13-22.29-33.171.36-43.220.542.33-
2022/60.17-25.97-72.711.23-44.140.652.11本月營收較去年同期減少 72.72%，主要係熟齡女性保健食品結束代理減少營收所致。
2022/50.23-5.96-29.621.05-32.560.682.04-
2022/40.2527.08-25.460.82-33.360.572.43-
2022/30.257.07-35.120.57-36.280.571.8-
2022/20.12-50.74-50.060.38-36.870.581.78本月較去年同期減少50.07%，主係受新冠肺炎疫情亦趨嚴峻而影響營收所致。
2022/10.2524.39-27.430.25-27.430.671.53-
2021/120.2-6.1-20.153.52-2.550.651.69-
2021/110.22-6.17-46.293.31-1.210.651.7-
2021/100.2314.72-32.93.14.930.71.57-
2021/90.2-24.78-38.492.879.910.671.82-
2021/80.2732.87-5.882.6616.841.11.11-
2021/70.2-68.27-26.112.420.081.171.05-
2021/60.6390.95121.482.227.361.31.06本月營收較去年同期增加 121.49%，主要係熟齡女性保健食品銷售增加所致。
2021/50.33-0.426.471.568.650.971.42-
2021/40.3310.612.721.234.680.881.55-
2021/30.320.9-8.060.91.980.92.04-
2021/20.25-28.42-9.860.67.920.852.15-
2021/10.3536.8825.690.3525.691.01.82-
2020/120.25-36.84-47.263.61-16.671.01.55-
2020/110.417.2239.623.35-12.841.071.44-
2020/100.345.15-5.282.95-17.090.951.62-
2020/90.3315.0923.52.61-18.430.881.63-
2020/80.284.31-30.162.28-22.210.841.71-
2020/70.27-4.89-20.462.0-20.930.821.76-
2020/60.299.03-24.491.72-21.00.841.8-
2020/50.26-11.23-28.881.44-20.270.891.72-
2020/40.3-9.79-23.861.18-18.060.91.69-
2020/30.3318.527.020.88-15.910.881.61-
2020/20.28-0.1827.80.55-25.381.041.37-
2020/10.28-42.57-47.280.28-47.280.0N/A-
2019/120.4867.210.534.33-18.80.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益率 YoY稅後淨利率 YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)490.0-0.640-0.8601.93-25.1917.35-32.04-21.280-16.490-0.410-0.310-0.320
2022 (9)490.0-0.140-0.3102.58-26.725.53-23.65-4.860-2.640-0.130-0.050-0.070
2021 (8)490.00.33-2.940.3962.53.52-4.3533.44-2.546.77102.694.611.770.24100.00.2116.670.16-5.88
2020 (7)490.00.34-33.330.2403.68-15.0134.318.13.341236.04.53-22.560.121100.00.18-30.770.17-32.0
2019 (6)49-2.00.5100.0004.33-18.4631.7423.210.2505.8500.0100.2600.250
2018 (5)500.0-1.240-0.8405.31-2.3925.76-20.17-7.430-11.690-0.390-0.610-0.620
2017 (4)5025.00.3663.64-0.2005.4462.8732.27-0.22-0.9803.3123.51-0.0500.2283.330.18100.0
2016 (3)4021.210.2200.2903.3465.3532.3432.325.1202.6800.1700.1200.090
2015 (2)33-21.43-3.280-1.1002.02-8.1824.441.83-5.880-53.680-0.120-0.670-1.090
2014 (1)420.0-1.010-1.0002.2-25.1724.000-5.050-19.160-0.110-0.040-0.420

免責聲明

本網站所有資料僅供參考，如使用者依本資料交易發生交易損失需自行負責，本網站對資料內容錯誤﹑更新延誤不負任何責任。